| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 1096 |
| 1 | PREDNISONE | 1010 |
| 2 | MONTELUKAST SODIUM | 804 |
| 3 | DUPILUMAB | 768 |
| 4 | OMALIZUMAB | 597 |
| 5 | ALBUTEROL | 545 |
| 6 | ACETAMINOPHEN | 523 |
| 7 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 490 |
| 8 | FLUTICASONE PROPIONATE | 485 |
| 9 | ADALIMUMAB | 450 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CICLESONIDE | 235 | 0.0171 |
| 1 | OSELTAMIVIR PHOSPHATE | 192 | 0.0079 |
| 2 | OMALIZUMAB | 597 | 0.0069 |
| 3 | IPRATROPIUM BROMIDE | 239 | 0.0066 |
| 4 | ROSUVASTATIN CALCIUM | 194 | 0.0066 |
| 5 | MONTELUKAST SODIUM | 804 | 0.0065 |
| 6 | AZITHROMYCIN MONOHYDRATE | 264 | 0.0062 |
| 7 | MOMETASONE FUROATE | 246 | 0.0058 |
| 8 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 206 | 0.0057 |
| 9 | TIOTROPIUM BROMIDE INHALATION SPRAY | 58 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1709 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1057 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 768 |
| 3 | Provitamin D2 Compound [EPC] | 635 |
| 4 | Interleukin-5 Antagonist [EPC] | 612 |
| 5 | Anti-IgE [EPC] | 597 |
| 6 | Benzodiazepine [EPC] | 595 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 535 |
| 8 | Proton Pump Inhibitor [EPC] | 487 |
| 9 | Loop Diuretic [EPC] | 481 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 612 | 0.8895 |
| 1 | Provitamin D2 Compound [EPC] | 635 | 0.0213 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 19 | 0.0092 |
| 3 | PCSK9 Inhibitor [EPC] | 234 | 0.0091 |
| 4 | Anti-IgE [EPC] | 597 | 0.0069 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 4 | 0.0053 |
| 6 | Pyrethroid [EPC] | 9 | 0.0051 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 134 | 0.0046 |
| 8 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 4 | 0.0044 |
| 9 | Human Immunoglobulin G [EPC] | 91 | 0.0043 |